The War on Cancer wages on and forty years after President Nixon signed the National Cancer Act into law, some big successes have followed; Breast cancer deaths fell about 28 percent from 1990 to 2006, while deaths from cervical cancer have dropped nearly 31 percent.

Colorectal deaths have fallen 28 percent in women and 33 percent in men; deaths from leukemia have fallen nearly 15 percent in women and 10 percent in men; and deaths from stomach cancer have fallen 34 percent in women and 43 percent in men.

Many more men are also surviving prostate cancer, with death rates falling 39 percent.

The National Cancer Act promised more funding for cancer research and prevention. Since then, death rates for many cancers have dropped significantly. From 1990 to 2007, death rates for all cancers combined dropped 22 percent for men and 14 percent for women, resulting in nearly 900,000 fewer deaths during that time, according to the report.

Today, more than 68 percent of adults live five years or more after being diagnosed, up from 50 percent in 1975. The five-year survival rate for all childhood cancers combined is 80 percent, compared to 52 percent in 1975.

There are about 12 million cancer survivors living in the United States; 15 percent of them were diagnosed 20 or more years ago.

That morning “Jo” may be more helpful than just an eye opening jolt of energy.

Whether caffeinated or decaffeinated studies show that men who drink one to three cups of coffee per day lower thier risk of aggressive prostate cancer by 13%.

More findings indicate that increased amounts of coffee continues to cut the overall risk.

The study, published in the Journal of the National Cancer Institute, also found men who drank six or more cups of coffee per day over some 20 years were 60 percent less likely to develop the more aggressive forms of prostate cancer.

According to a new study from University of Michigan discover how prostate cancer cells spread to the bones. Science offers hope for the treatment of prostate cancer

So why does cancer recur? Say a person has a tumor and surgeons cut it out or do radiation, but it recurs in the bone marrow five years later, Taichman said. Those cancer cells had been circulating in the body well before the tumor was discovered, and one place those cancer cells hid is the niche.

“So what have the cancer cells been doing during those five years? Now we have a partial answer — they’ve been sitting in this place whose job it is to keep things from proliferating and growing,” Taichman said.

“Our work also provides an explanation as to why current chemotherapies often fail in that once cancer cells enter the niche, most likely they stop proliferating,” said Yusuke Shiozawa, lead author of the study. “The problem is that most of the drugs we use to try to treat cancer only work on cells that are proliferating.”